CVR number 39897393
Industry 869600

Kiropraktisk Klinik Assens ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.1% 4.5% 3.9% 4.2% 3.3%  
Credit score (0-100)  40 46 48 48 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  3,009 2,775 3,061 3,180 2,926  
Gross profit  2,346 2,475 2,675 2,677 2,805  
EBITDA  433 617 716 661 435  
EBIT  94.8 321 421 360 209  
Pre-tax profit (PTP)  15.7 266.9 382.2 335.9 195.2  
Net earnings  5.6 208.0 297.7 262.9 153.1  
Pre-tax profit without non-rec. items  15.7 267 382 336 195  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  260 170 81.0 115 131  
Shareholders equity total  106 314 411 474 427  
Interest-bearing liabilities  1,715 1,100 810 537 531  
Balance sheet total (assets)  2,096 1,883 1,550 1,288 1,143  
Net Debt  1,481 751 473 303 248  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  3,009 2,775 3,061 3,180 2,926  
Net sales growth  0.0% -7.8% 10.3% 3.9% -8.0%  
Gross profit  2,346 2,475 2,675 2,677 2,805  
Gross profit growth  0.0% 5.5% 8.1% 0.1% 4.7%  
Employees  6 4 5 5 5  
Employee growth %  0.0% -33.3% 25.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,096 1,883 1,550 1,288 1,143  
Balance sheet change%  0.0% -10.2% -17.7% -16.9% -11.2%  
Added value  433.1 616.7 716.2 655.8 435.3  
Added value %  14.4% 22.2% 23.4% 20.6% 14.9%  
Investments  1,331 -591 -591 -474 -416  
Net sales trend  0.0 -1.0 1.0 2.0 -1.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  14.4% 22.2% 23.4% 20.8% 14.9%  
EBIT %  3.2% 11.6% 13.7% 11.3% 7.1%  
EBIT to gross profit (%)  4.0% 13.0% 15.7% 13.5% 7.5%  
Net Earnings %  0.2% 7.5% 9.7% 8.3% 5.2%  
Profit before depreciation and extraordinary items %  11.4% 18.2% 19.4% 17.7% 13.0%  
Pre tax profit less extraordinaries %  0.5% 9.6% 12.5% 10.6% 6.7%  
ROA %  4.6% 16.2% 24.5% 25.4% 17.3%  
ROI %  3.0% 13.8% 31.4% 32.3% 21.2%  
ROE %  5.3% 99.2% 82.1% 59.4% 34.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  5.0% 16.7% 26.5% 36.8% 37.4%  
Relative indebtedness %  66.1% 56.6% 37.2% 25.6% 24.1%  
Relative net indebtedness %  58.4% 44.0% 26.2% 18.2% 14.4%  
Net int. bear. debt to EBITDA, %  342.0% 121.8% 66.0% 45.9% 57.0%  
Gearing %  1,624.3% 350.6% 196.9% 113.2% 124.3%  
Net interest  0 0 0 0 0  
Financing costs %  9.4% 3.9% 4.0% 3.6% 2.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 0.9 1.4 1.4 2.4  
Current Ratio  0.7 0.9 1.4 1.4 2.5  
Cash and cash equivalent  234.2 348.3 337.2 233.3 282.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  14.0 15.0 10.9 12.3 12.5  
Trade creditors turnover (days)  22.6 34.9 11.6 10.7 11.3  
Current assets / Net sales %  14.2% 18.4% 15.4% 12.0% 14.6%  
Net working capital  -175.1 -81.1 142.8 105.0 253.2  
Net working capital %  -5.8% -2.9% 4.7% 3.3% 8.7%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  502 694 612 636 585  
Added value / employee  72 154 143 131 87  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  72 154 143 132 87  
EBIT / employee  16 80 84 72 42  
Net earnings / employee  1 52 60 53 31